Ares Capital (NASDAQ:ARCC) Stock Rating Downgraded by

Ares Capital (NASDAQ:ARCC – Get a rating) was downgraded by from a “hold” rating to a “sell” rating in a research report published Tuesday.

Other research analysts have also recently published reports on the company. Wells Fargo & Company raised its price target on Ares Capital from $22.50 to $23.00 and gave the company an “overweight” rating in a Monday, April 25 research report. JPMorgan Chase & Co. upgraded Ares Capital from a “neutral” rating to an “overweight” rating and set a $22.00 price target for the company in a Wednesday, April 27 research report. Raymond James raised his price target on Ares Capital from $22.00 to $23.00 and gave the company an “outperform” rating in a Thursday, February 10 research report. TheStreet upgraded Ares Capital from a “b-” to a “c+” rating in a Monday, May 23 report. Finally, Hovde Group lowered its price target on Ares Capital to $19.00 in a Friday May 20 research note. One research analyst has assigned the stock a sell rating, one has assigned a hold rating and seven have assigned the company a buy rating. According to, Ares Capital currently has a consensus rating of “Buy” and an average target price of $22.13.

Ares Capital stock traded down $0.04 on Tuesday, hitting $19.86. The company’s shares had a trading volume of 2,201,683 shares, compared to its average volume of 3,896,589. The company has a debt ratio of 1.13, a quick ratio of 1.91 and a current 1.91. The company has a market capitalization of $9.79 billion, a price-earnings ratio of 6.45 and a beta of 1.01. The company’s fifty-day moving average price is $20.33 and its 200-day moving average price is $20.79. Ares Capital has a 12-month low of $17.79 and a 12-month high of $23.00.

(A d)

This under-the-radar stock’s bulletproof patent could propel it into another dimension.

Ares Capital (NASDAQ:ARCC – Get Rating) last released its quarterly results on Tuesday, April 26. The investment management firm reported earnings per share (EPS) of $0.41 for the quarter, missing the consensus estimate of $0.47 per ($0.06). Ares Capital had a net margin of 75.13% and a return on equity of 10.23%. The company posted revenue of $440.00 million for the quarter, versus analyst estimates of $486.12 million. During the same period last year, the company achieved EPS of $0.43. The company’s revenue increased by 12.8% compared to the same quarter last year. As a group, stock analysts expect Ares Capital to post 1.77 earnings per share for the current year.

In other Ares Capital news, insider Michael Lewis Smith bought 54,000 shares of the company in a trade dated Thursday, May 19. The shares were purchased at an average price of $18.64 per share, for a total transaction of $1,006,560.00. Following the transaction, the insider now owns 89,000 shares of the company, valued at approximately $1,658,960. The transaction was disclosed in a document filed with the SEC, which can be accessed on the SEC’s website. Additionally, director Mary Beth Henson purchased 6,000 shares of the company in a transaction dated Monday, March 14. The shares were acquired at an average price of $20.05 per share, with a total value of $120,300.00. Disclosure of this purchase can be found here. 0.59% of the shares are currently held by insiders of the company.

A number of large investors have recently increased or reduced their stake in ARCC. Zullo Investment Group Inc. acquired a new stake in Ares Capital in the fourth quarter worth approximately $27,000. Atticus Wealth Management LLC increased its stake in Ares Capital shares by 88.1% in the 4th quarter. Atticus Wealth Management LLC now owns 1,482 shares of the investment management company valued at $31,000 after acquiring an additional 694 shares during the period. Financial Management Professionals Inc. increased its position in Ares Capital shares by 70.7% in the 1st quarter. Financial Management Professionals Inc. now owns 1,775 shares of the investment management company worth $37,000 after purchasing an additional 735 shares in the last quarter. Steph & Co. acquired a new equity stake in Ares Capital in Q4 worth $42,000. Finally, Hardy Reed LLC acquired a new equity stake in Ares Capital in Q1 worth $42,000. Institutional investors hold 29.44% of the company’s shares.

About Ares Capital (Get an assessment)

Ares Capital Corporation is a business development firm specializing in the acquisition, recapitalization, mezzanine debt, restructurings, rescue financing and leveraged buyout transactions of middle market companies. He also does growth capital and general refinancing. He prefers to invest in companies active in basic and growth manufacturing, business services, consumer products, healthcare products and services, and information technology services.

See also

Analyst Recommendations for Ares Capital (NASDAQ: ARCC)

This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Ares Capital right now?

Before you consider Ares Capital, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Ares Capital was not on the list.

While Ares Capital currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

Previous Misinformation Obscures America's Most Popular Emergency Contraception
Next Florida faces $1.2 million verdict for killing citrus trees